BCL2 and non-small cell lung carcinoma: Its mechanism of action involves the modulation of the expression levels of the Bcl-2 protein family through the mitochondrial pathway, subsequently triggering a cascade of caspase reactions and ultimately inducing apoptosis in NSCLC cells.